| Financial Year |
March 31 2023 |
| Monetary Funds |
217,873,825.46 |
| Held-for-trading Financial Assets |
217,456,874.18 |
| Notes Receivable |
-- |
| Accounts Receivable |
102,084,133.15 |
| Advances to Suppliers |
205,537,456.09 |
| Other Receivables |
16,181,840.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,261,688.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
118,138,948.24 |
| Other Current Assets |
86,269,823.74 |
| Total Current Assets |
977,365,684.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
153,375,417.66 |
| Investment Properties |
85,735,138.85 |
| Fixed Assetes |
26,002,602.67 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
292,577,453.15 |
| R&D expenses |
-- |
| Goodwill |
221,929.74 |
| Long-Term Deferred and Prepaid Expenses |
1,555,297.49 |
| Deferred Income Tax Assets |
1,639,029.91 |
| Other Non-Current Assets |
3,313,707.00 |
| Sub-Total of Non-Current Assets |
794,627,342.59 |
| Total Assets |
1,771,993,026.99 |
| Short-Term Loans |
220,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
96,950,027.92 |
| Accounts Received In Advance |
1,405,704.36 |
| Employee Compensation Payable |
62,109,542.48 |
| Taxes Payable |
2,160,493.99 |
| Interest Payable |
235,690.45 |
| Dividend Payable |
-- |
| Other payables |
17,658,501.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,830,797.73 |
| Other Current Liabilities |
2,093,938.08 |
| Sub-Total of Current Liabilities |
566,514,348.72 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
7,000,000.00 |
| Deferred Income Tax Liabilities |
5,162,241.68 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
29,786,281.68 |
| Total Liabilities |
596,300,630.40 |
| Paid-In Capital(Or Share Stock) |
729,939,618.00 |
| Capital Surplus |
2,488,984,948.70 |
| Surplus Reserve |
30,930,203.91 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,067,515,959.47 |
| Minority Stockholder's Interest |
59,271,184.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,116,421,211.73 |
| Owner's Equity（Stockholder's Equity） |
1,175,692,396.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,771,993,026.99 |
